Jamshid Hadjati

3PUBLICATIONS
7CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Nov 19, 2021
Targeting hypoxia and hypoxia-inducible factor-1 in the tumor microenvironment for optimal cancer immunotherapy.

Nasim Kheshtchin, Jamshid Hadjati

|May 24, 2019
Sodium Butyrate as a Histone Deacetylase Inhibitor Affects Toll-Like Receptor 4 Expression in Colorectal Cancer Cell Lines.

Nazanin Atieh Kazemi Sefat, Mohammad Mahdi Mohammadi, Jamshid Hadjati

|Oct 27, 2018
Construction and functional characterization of a fully human anti-CD19 chimeric antigen receptor (huCAR)-expressing primary human T cells.

Hamid Reza Mirzaei, Arezoo Jamali, Leila Jafarzadeh

Pageof 1